Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 2,539 | 2,033 | 1,562 | 2,034 | 1,938 |
| Cost of Goods | 1,519 | 1,184 | 1,060 | 1,258 | 1,120 |
| Gross Profit | 1,020 | 849 | 503 | 776 | 818 |
| Operating Expenses | 2,687 | 1,922 | 1,436 | 1,327 | 898 |
| Operating Income | -1,148 | -890 | -874 | -293 | 39 |
| Interest Expense | 9 | 10 | 10 | 11 | 6 |
| Other Income | 0 | 0 | 1 | 0 | 0 |
| Pre-tax Income | -1,156 | -899 | -883 | -304 | 34 |
| Net Income Continuous | -1,156 | -899 | -883 | -304 | 34 |
| Net Income | $-1,156 | $-899 | $-883 | $-304 | $34 |
| EPS Basic Total Ops | -0.06 | -0.06 | -0.03 | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -0.06 | -0.07 | -0.04 | -0.02 | 0.00 |
| EPS Diluted Total Ops | -0.06 | -0.06 | -0.03 | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -0.06 | -0.07 | -0.04 | -0.02 | 0.00 |
| EBITDA(a) | $-1,048 | $-790 | $-774 | $-197 | $132 |